Elevated levels of tumor necrosis factor alpha and mortality in centenarians

American Journal of Medicine

Volumn 115, Issue 4, 2003, Pages 278-283

  Bruunsgaard, Helle ^a   Andersen Ranberg, Karen ^b   Hjelmborg, Jacob V B ^b   Pedersen, Bente Klarlund ^a   Jeune, Bernard ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMENTIA; FEMALE; HAZARD; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS;

EID: 0041878545     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(03)00329-2     Document Type: Article

References (33)

1. Bruunsgaard H., Pedersen M., Pedersen B.K. Aging and proinflammatory cytokines. Curr Opin Hematol. 8:2001;131-136.
2. Bruunsgaard H., Andersen-Ranberg K., Jeune B., et al. A high plasma concentration of TNF-alpha is associated with dementia in centenarians. J Gerontol Med Sci. 54A:1999;M357-M364.
3. Bruunsgaard H., Skinhøj P., Pedersen A.N., et al. Ageing, TNF-alpha and atherosclerosis. Clin Exp Immunol. 21:2000;255-260.
4. Cohen H.J., Pieper C.F., Harris T., et al. The association of plasma IL-6 levels with functional disability in community dwelling elderly. J Gerontol Med Sci. 52A:1997;M201-M208.
5. Volpato S., Guralnik J.M., Ferrucci L., et al. Cardiovascular disease, interleukin-6, and risk of mortality in older women the women's health and aging study . Circulation. 103:2001;947-953.
6. Harris T.B., Ferrucci L., Tracy R.P., et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med. 106:1999;506-512.
7. Andersen-Ranberg K., Schroll M., Jeune B. Healthy centenarians do not exist, but autonomous centenarians do a population-based study of morbidity among Danish centenarians . J Am Geriatr Soc. 49:2001;900-908.
8. Fillit H., Ding W.H., Buee L., et al. Elevated circulating tumor necrosis factor levels in Alzheimer's disease. Neurosci Lett. 129:1991;318-320.
9. Richards C., Gauldie J. Role of cytokines in the acute-phase response. Aggarwal B.B., Puri R.K. Human Cytokines Their Roles in Disease and Therapy . 1995;253-269 Blackwell Science, Cambridge, MA.
10. Andersen-Ranberg K., Vasegaard L., Jeune B. Dementia is not inevitable. A population-based study of Danish centenarians. J Gerontol. 56B:2001;P152-P159.
11. Hughes C.P., Berg L., Martin R.L. A new clinical stage for the staging of dementia. Br J Psychiatr. 140:1982;566-572.
12. Vaupel J.W., Carey J.R., Christensen K., et al. Biodemographic trajectories of longevity. Science. 280:1998;855-860.
13. Collet D. Stratified proportional hazards models. Chatfield C., Zidek J.V. Modelling Survival Data in Medical Research. 2003;267-271 Chapman and Hall/CRC, London.
14. Akaike A. Information theory and an extension of the maximum likelihood principle. Petrov V.N., Csaki F. 2nd International Symposium on Information Theory. 1973;267-281 Akailseoniai-Kiudo, Budapest.
15. Mooradian A.D., Reed R.L., Osterweil D., Scuderi P. Detectable serum levels of tumor necrosis factor alpha may predict early mortality in elderly institutionalized patients. J Am Geriatr Soc. 39:1991;891-894.
16. Akiyama H., Barger S., Barnum S., et al. Inflammation and Alzheimer's disease. Neurobiol Aging. 21:2000;383-421.
17. Pan W., Kastin A.J. TNFalpha transport across the blood-brain barrier is abolished in receptor knockout mice. Exp Neurol. 174:2002;193-200.
18. Hotamisligil G.S. The role of TNF-alpha and TNF receptors in obesity and insulin resistance. J Intern Med. 245:1999;621-625.
19. Grunfeld C., Palladino M. Tumor necrosis factor immunologic, antitumor, metabolic, and cardiovascular activities . Adv Intern Med. 35:1990;45-71.
20. Bhagat K., Vallance P. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation. 96:1997;3042-3047.
21. Meager A. Cytokine regulation of cellular adhesion molecule expression in inflammation. Cytokine Growth Factor Rev. 10:1999;27-39.
22. Hoshino E., Pichard C., Greenwood C.E., et al. Body composition and metabolic rate in rat during a continuous infusion of cachectin. Am J Physiol. 260:1991;E27-E36.
23. Tisdale M.J. Wasting in cancer. J Nutr. 129:(suppl):1999;243S-246S.
24. Reid M.B., Li Y.P. Tumor necrosis factor-alpha and muscle wasting a cellular perspective . Respir Res. 2:2001;269-272.
25. Roubenoff R., Grinspoon S., Skolnik P.R., et al. Role of cytokines and testosterone in regulating lean body mass and resting energy expenditure in HIV-infected men. Am J Physiol Endocrinol Metab. 283:2002;E138-E145.
26. Roubenoff R., Roubenoff R.A., Cannon J.G., et al. Rheumatoid cachexia cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation . J Clin Invest. 93:1994;2379-2386.
27. Hamerman D. Toward an understanding of frailty. Ann Intern Med. 130:1999;945-950.
28. Visser M., Pahor M., Taaffe D.R., et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women the Health ABC Study . J Gerontol Med Sci. 57A:2002;M326-M332.
29. Fried L.P., Tangen C.M., Walston J., et al. Frailty in older adults evidence for a phenotype . J Gerontol Med Sci. 56A:2001;M146-M156.
30. Metzger S., Hassin T., Barash V., et al. Reduced body fat and increased hepatic lipid synthesis in mice bearing interleukin-6-secreting tumor. Am J Physiol Endocrinol Metab. 281:2001;E957-E965.
31. Xing Z., Gauldie J., Cox G., et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest. 101:1998;311-320.
32. Tilg H., Trehu E., Atkins M.B., et al. Interleukin-6 (IL-6) as an anti-inflammatory cytokine induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55 . Blood. 83:1994;113-118.
33. Kerr R., Stirling D., Ludlam C.A. Interleukin 6 and haemostasis. Br J Haematol. 115:2001;3-12.